Cellular and gene therapies are expected to represent one of the greatest advances in medical treatments since the introduction of monoclonal antibodies. These therapies present an enormous industry opportunity for those who are able to overcome the unique obstacles of developing cell and gene thereapy products.

This webinar addresses the complex path to developing and commercializing a cell and gene therapy product, common obstacles, strategies for patient recruitment and more. Attendees will learn:

  • The clinical potential for cell and gene therapies
  • Steps to avoid barriers for trial delivery
  • How to implement effective strategies for patient recruitment inclusive of pediatric populations
  • Protocols for minimal patient burden and maximal study procedure compliance